Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
BlackRock Inc.
> XENE
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Xenon Pharmaceuticals Inc. | XENE | 994,040 | 94,886 | 38,270,544,000 | 6,089,821,000 | $38,500.00 |
| 03/31/2023 | Xenon Pharmaceuticals Inc. | XENE | 899,154 | -143,375 | 32,180,723,000 | 32,143,089,000 | $35,790.00 |
| 09/30/2022 | Xenon Pharmaceuticals Inc. | XENE | 1,042,529 | 174,239 | 37,634,000 | 11,221,000 | $36.10 |
| 06/30/2022 | Xenon Pharmaceuticals Inc. | XENE | 868,290 | 253,333 | 26,413,000 | 7,612,000 | $30.42 |
| 03/31/2022 | Xenon Pharmaceuticals Inc. | XENE | 614,957 | 47,385 | 18,801,000 | 1,068,000 | $30.57 |
| 12/31/2021 | Xenon Pharmaceuticals Inc. | XENE | 567,572 | 124,520 | 17,733,000 | 10,962,000 | $31.24 |
| 09/30/2021 | Xenon Pharmaceuticals Inc. | XENE | 443,052 | 31,800 | 6,771,000 | -887,000 | $15.28 |
| 06/30/2021 | Xenon Pharmaceuticals Inc. | XENE | 411,252 | 13,129 | 7,658,000 | 533,000 | $18.62 |
| 03/31/2021 | Xenon Pharmaceuticals Inc. | XENE | 398,123 | -21,420 | 7,125,000 | 672,000 | $17.90 |
| 12/31/2020 | Xenon Pharmaceuticals Inc. | XENE | 419,543 | 350,651 | 6,453,000 | 5,690,000 | $15.38 |
| 09/30/2020 | Xenon Pharmaceuticals Inc. | XENE | 68,892 | -251 | 763,000 | -103,000 | $11.08 |
| 06/30/2020 | Xenon Pharmaceuticals Inc. | XENE | 69,143 | 61,436 | 866,000 | 779,000 | $12.52 |
| 03/31/2020 | Xenon Pharmaceuticals Inc. | XENE | 7,707 | 7,707 | 87,000 | 87,000 | $11.29 |
| 12/31/2019 | Xenon Pharmaceuticals Inc. | XENE | 0 | -256,667 | 0 | -2,312,000 | |
| 09/30/2019 | Xenon Pharmaceuticals Inc. | XENE | 256,667 | -1,947 | 2,312,000 | 2,309,450 | $9.01 |
| 06/30/2019 | Xenon Pharmaceuticals Inc. | XENE | 258,614 | -8,963 | 2,550 | -2,716,450 | $0.01 |
| 03/31/2019 | Xenon Pharmaceuticals Inc. | XENE | 267,577 | -16,131 | 2,719,000 | 929,000 | $10.16 |
| 12/31/2018 | Xenon Pharmaceuticals Inc. | XENE | 283,708 | 283,708 | 1,790,000 | 1,790,000 | $6.31 |
| << Prev Next >> |
|